NAUTILUS BIOTECHNOLOGY
LIVE

Serial Number

97672465

Owner

Nautilus Biotechnology, Inc.

Attorney

Carla B. Oakley

Filing Date

Nov 10, 2022

Add to watchlist:

No watchlists yet
View on USPTO

NAUTILUS BIOTECHNOLOGY Trademark

Serial Number: 97672465

NAUTILUS BIOTECHNOLOGY is a trademark filed by Nautilus Biotechnology, Inc. on November 10, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Nautilus Biotechnology, Inc. (2 trademarks)

2701 Eastlake Ave East, Suite 300
Seattle, WA 98102

Entity Type: 03

Trademark Details

Filing Date

November 10, 2022

Registration Date

Not Registered

Published for Opposition

October 3, 2023

Goods & Services

Laboratory equipment, namely, a device for molecular analysis of proteins; laboratory instrument for protein analysis including chemical and biochemical reactions; medical laboratory research instrument for molecular analysis and sequencing including chemical and biochemical reactions; automated laboratory apparatus and computer systems for use in analysis of biomolecules; proteome quantifiers in the nature of proteome analyzers; laboratory equipment, namely, fluid containers, fluid mixers, fluid control valves and temperature-controlled incubators for sample preparation, amplification, mixing, hybridization, incubation, and washing; automated laboratory apparatus and systems, namely, sample loaders and bar code readers; laboratory equipment, namely, an apparatus for screening samples, detecting the presence of analytes in samples, and identifying sample type, together with measuring patterns and laboratory equipment for making molecular arrays, and parts therefor

Medical testing for diagnostic or treatment purposes

Assays and reagents for use in biologic and medical research; diagnostic reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use; reagents and reagent kits comprised primarily of amino acids, naturally occurring or modified proteins, affinity reagents, enzymes, chemical or nano-particle labels, and chemical buffers, all for the purpose of preparing, detecting, sequencing, quantifying and analyzing proteins and other biological molecules, samples of biological molecules, proteins, proteomes, protein sequence variants and modifications, regulation, translation, and expression in the fields of scientific, diagnostic and clinical research; chemical standards solutions used in DNA, RNA and protein analysis, chemicals used in protein analysis systems; DNA labeling reagents; DNA hybridization buffers solutions

Scientific research; medical research; Protein screening for scientific research purposes; cloud hosting provider services for storing, analyzing and sharing biological information; providing an online network service that enables users to store, analyze and share data in the field of life sciences; technical support services, namely, infrastructure management services for monitoring, administration and management of cloud computing IT and application systems in the field of life sciences; design and development of laboratory apparatus and instruments and computer systems for use in analysis of biomolecules; installation and maintenance of computer software and databases used in the field of analysis of biomolecules; consultancy, information and advisory services in the field of analysis of biomolecules; product development, namely, developing equipment for use in preparing, detecting, sequencing, quantifying and analyzing proteins and other biological molecules, and automated laboratory equipment and systems, and computer systems for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data to the order and specification of others, all the foregoing in the fields of scientific and clinical research

Reagents for medical use; clinical medical reagents; medical diagnostic reagents and assays for testing bodily fluids; diagnostic biomarker reagents for medical purposes; medical diagnostic reagents and assays for testing cells, bodily fluids and tissue for disease detection, monitoring and prognosis

Filing History

SOU TEAS EXTENSION RECEIVED
May 8, 2026 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 8, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 8, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 8, 2026 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 20, 2025 EXRA
SOU EXTENSION 4 GRANTED
Nov 19, 2025 EX4G
SOU EXTENSION 4 FILED
Nov 19, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Nov 19, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 7, 2025 EXRA
SOU EXTENSION 3 GRANTED
May 7, 2025 EX3G
SOU EXTENSION 3 FILED
May 7, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
May 6, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 31, 2024 EXRA
SOU EXTENSION 2 GRANTED
Oct 31, 2024 EX2G
SOU EXTENSION 2 FILED
Oct 31, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 31, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 21, 2024 EXRA
SOU EXTENSION 1 GRANTED
May 20, 2024 EX1G
SOU EXTENSION 1 FILED
May 20, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
May 20, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 28, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 3, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 3, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 13, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 25, 2023 CNSA
ASSIGNED TO EXAMINER
Aug 23, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 1, 2022 NWOS
NEW APPLICATION ENTERED
Nov 14, 2022 NWAP